
Current Price | $21.51 | Mkt Cap | $682.1M |
---|---|---|---|
Open | $21.25 | P/E Ratio | 0.00 |
Prev. Close | $21.51 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $20.59 - $21.71 | Volume | 1,247,112 |
52-Wk Range | $18.15 - $95.98 | Avg. Daily Vol. | 1,116,644 |
Current Price | $21.51 | Mkt Cap | $682.1M |
---|---|---|---|
Open | $21.25 | P/E Ratio | 0.00 |
Prev. Close | $21.51 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $20.59 - $21.71 | Volume | 1,247,112 |
52-Wk Range | $18.15 - $95.98 | Avg. Daily Vol. | 1,116,644 |
The best Bull and Bear pitches based on recency and number of recommendations.
Intercept up 23% premarket on positive OCA dataFeb. 19, 2019 7:43 AM ET|About: Intercept Pharmaceuticals (ICPT)|By: Douglas W. House, SA News EditorIntercept Pharmaceuticals (NASDAQ:ICPT) is up 23% premarket on light volume following its announcement… More
Company is too reliant on one drug and whether its lead drug gets approval as a treatment for NASH. However, that all changes if it does get approval.
Read the most recent pitches from players about ICPT.
Recs
Revenue growth plus possibility of huge blockbuster drug approval on the horizon - NASH
Recs
Company is too reliant on one drug and whether its lead drug gets approval as a treatment for NASH. However, that all changes if it does get approval.
Recs
this goes up and down in alot of volume
Find the members with the highest scoring picks in ICPT.
alkusari (< 20) Score: +443.87
The Score Leader is the player with the highest score across all their picks in ICPT.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
jjc007007 | 71.36 | 2/5/2014 |
![]() |
5Y | $296.00 | -92.73% | +117.52% | +210.25 | 0 Comment | |
Halffrenzy | 26.23 | 1/10/2014 |
![]() |
5Y | $438.98 | -95.10% | +108.42% | +203.52 | 0 Comment | |
sinvestor | 53.44 | 1/14/2014 |
![]() |
3M | $361.00 | -94.04% | +109.41% | +203.46 | 1 Comment | |
vzwatmrk | < 20 | 1/10/2014 |
![]() |
5Y | $455.50 | -95.28% | +108.00% | +203.28 | 0 Comment | |
kevrose31 | 80.31 | 1/10/2014 |
![]() |
1Y | $373.00 | -94.23% | +107.51% | +201.75 | 0 Comment | |
kayakmastr | 89.68 | 1/13/2014 |
![]() |
1Y | $339.87 | -93.67% | +107.78% | +201.46 | 0 Comment | |
alexeysm | 32.84 | 1/13/2014 |
![]() |
1Y | $339.87 | -93.67% | +107.78% | +201.46 | 0 Comment | |
Figgie27 | < 20 | 1/13/2014 |
![]() |
3M | $339.87 | -93.67% | +107.78% | +201.46 | 0 Comment | |
Brandonrules | < 20 | 4/11/2014 |
![]() |
5Y | $260.33 | -91.74% | +109.54% | +201.28 | 0 Comment | |
IBDContrarian | 81.13 | 12/18/2012 |
![]() |
5Y | $34.40 | -37.47% | +163.78% | +201.25 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.